These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30507294)

  • 21. [Analgesic management of acute pain in patients receiving methadone or buprenorphine].
    Zinck L; Sonne NM; Madsen SL; Nikolajsen L
    Ugeskr Laeger; 2015 Mar; 177(10):. PubMed ID: 25749118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion.
    Webster L; Gudin J; Raffa RB; Kuchera J; Rauck R; Fudin J; Adler J; Mallick-Searle T
    Pain Med; 2020 Apr; 21(4):714-723. PubMed ID: 31917418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buprenorphine: considerations for pain management.
    Johnson RE; Fudala PJ; Payne R
    J Pain Symptom Manage; 2005 Mar; 29(3):297-326. PubMed ID: 15781180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting medication persistence to buprenorphine transdermal system.
    Pergolizzi JV; Ben-Joseph R; Chang CL; Hess G
    Pain Pract; 2015 Feb; 15(2):140-9. PubMed ID: 24444055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transdermal System-Buprenorphine and Fentanyl].
    Sakurai H
    Masui; 2015 Nov; 64(11):1145-50. PubMed ID: 26689065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing long-term high-dose prescription opioids in patients with non-cancer pain: The potential role of sublingual buprenorphine.
    Chong J; Frei M; Lubman DI
    Aust J Gen Pract; 2020 Jun; 49(6):339-343. PubMed ID: 32464722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Chronic Pain With Various Buprenorphine Formulations: A Systematic Review of Clinical Studies.
    Aiyer R; Gulati A; Gungor S; Bhatia A; Mehta N
    Anesth Analg; 2018 Aug; 127(2):529-538. PubMed ID: 29239947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buprenorphine use for pain and suicidal ideation in severely suicidal patients.
    Gibbs HM; Price D; Delgado PL; Clothier JL; Cáceda R
    Int J Psychiatry Med; 2020 Nov; 55(6):387-396. PubMed ID: 32216493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine: revisiting the efficacy of transdermal delivery system.
    Kitzmiller JP; Barnett CJ; Steiner NS; Stoicea N; Kamar N; Luzum JA; Mikulik E; Bergese SD
    Ther Deliv; 2015; 6(4):419-22. PubMed ID: 25996041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system.
    Pergolizzi JV; Ben-Joseph R; Chang CL; Hess G
    Curr Med Res Opin; 2014 Aug; 30(8):1579-87. PubMed ID: 24689806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal buprenorphine controls central neuropathic pain.
    Weiner M; Sarantopoulos C; Gordon E
    J Opioid Manag; 2012; 8(6):414-5. PubMed ID: 23264319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal buprenorphine (Butrans) for chronic pain.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):31-2. PubMed ID: 21502936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative Pain and Addiction Interdisciplinary Network (PAIN) clinical practice advisory for perioperative management of buprenorphine: results of a modified Delphi process.
    Goel A; Azargive S; Weissman JS; Shanthanna H; Hanlon JG; Samman B; Dominicis M; Ladha KS; Lamba W; Duggan S; Di Renna T; Peng P; Wong C; Sinha A; Eipe N; Martell D; Intrater H; MacDougall P; Kwofie K; St-Jean M; Rashiq S; Van Camp K; Flamer D; Satok-Wolman M; Clarke H
    Br J Anaesth; 2019 Aug; 123(2):e333-e342. PubMed ID: 31153631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of analgesic potency and side effects of buprenorphine and buprenorphine with ultra-low-dose naloxone.
    Ling W; Hillhouse M; Jenkins J; Miotto K; Torrington M; Chapleo C
    J Addict Med; 2012 Jun; 6(2):118-23. PubMed ID: 22475985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlling the Swing of the Opioid Pendulum.
    Comerci G; Katzman J; Duhigg D
    N Engl J Med; 2018 Feb; 378(8):691-693. PubMed ID: 29466151
    [No Abstract]   [Full Text] [Related]  

  • 36. Opioids for persistent pain in older adults.
    Galicia-Castillo M
    Cleve Clin J Med; 2016 Jun; 83(6):443-51. PubMed ID: 27281257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain.
    Miller K; Yarlas A; Wen W; Dain B; Lynch SY; Brennan MJ; Ripa SR
    Expert Opin Pharmacother; 2013 Feb; 14(3):269-77. PubMed ID: 23374027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steering patients to relief from chronic low back pain: opioids' role.
    Chou R
    J Fam Pract; 2013 Mar; 62(3 Suppl):S8-13. PubMed ID: 23520591
    [No Abstract]   [Full Text] [Related]  

  • 39. The unique role of transdermal buprenorphine in the global chronic pain epidemic.
    Pergolizzi JV; Scholten W; Smith KJ; Leighton-Scott J; Willis JC; Henningfield JE
    Acta Anaesthesiol Taiwan; 2015 Jun; 53(2):71-6. PubMed ID: 26205326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain.
    Wolff RF; Aune D; Truyers C; Hernandez AV; Misso K; Riemsma R; Kleijnen J
    Curr Med Res Opin; 2012 May; 28(5):833-45. PubMed ID: 22443154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.